Suppr超能文献

两株严重急性呼吸综合征冠状病毒在Vero细胞培养传代后的基因组序列变异分析

Genome sequence variation analysis of two SARS coronavirus isolates after passage in Vero cell culture.

作者信息

Jin Weiwu, Hu Liangxiang, Du Zhenglin, Gao Qiang, Gao Hong, Ning Ye, Feng Jidong, Zhang Jiansan, Yin Weidong, Li Ning

机构信息

1State Key Laboratory for Agrobiotechnology, China Agricultural University, 100094 Beijing, China.

Sino Biotech Co., Ltd., No. 39 Shangdi Xi Rd. Haidian District, 100085 Beijing, China.

出版信息

Chin Sci Bull. 2004;49(17):1824-1827. doi: 10.1007/BF03183408.

Abstract

SARS coronavirus is an RNA virus whose replication is error-prone, which provides possibility for escape of host defenses, and even leads to evolution of new viral strains during the passage or the transmission. Lots of variations have been detected among different SARS-CoV strains. And a study on these variations is helpful for development of efficient vaccine. Moreover, the test of nucleic acid characterization and genetic stability of SARS-CoV is important in the research of inactivated vaccine. The whole genome sequences of two SARS coronavirus strains after passage in Vero cell culture were determined and were compared with those of early passages, respectively. Results showed that both SARS coronavirus strains have high genetic stability, although nearly 10 generations were passed. Four nucleotide variations were observed between the second passage and the 11th passage of Sino1 strain for identification of SARS inactivated vaccine. Moreover, only one nucleotide was different between the third passage and the 10th passage of Sino3 strain for SARS inactivated vaccine. Therefore, this study suggested it was possible to develop inactivated vaccine against SARS-CoV in the future.

摘要

严重急性呼吸综合征冠状病毒是一种RNA病毒,其复制容易出错,这为逃避宿主防御提供了可能性,甚至在传代或传播过程中导致新病毒株的进化。在不同的严重急性呼吸综合征冠状病毒(SARS-CoV)毒株中已检测到许多变异。对这些变异的研究有助于开发高效疫苗。此外,SARS-CoV核酸特性和遗传稳定性的检测在灭活疫苗研究中很重要。测定了在Vero细胞培养物中传代后的两株SARS冠状病毒毒株的全基因组序列,并分别与早期传代的序列进行了比较。结果表明,尽管传代了近10代,但两株SARS冠状病毒毒株均具有较高的遗传稳定性。在用于SARS灭活疫苗鉴定的Sino1毒株的第二代传代和第十一代传代之间观察到四个核苷酸变异。此外,用于SARS灭活疫苗的Sino3毒株的第三代传代和第十代传代之间仅一个核苷酸不同。因此,本研究表明未来有可能开发出针对SARS-CoV的灭活疫苗。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验